Aesthetic Medicine Market Size, Share & Trends Analysis Report By Procedure Type (Invasive Procedures, Non-invasive Procedures), By Region (North America, Europe, APAC, LATAM, MEA), And Segment Forecasts, 2022 - 2030

Aesthetic Medicine Market Growth & Trends

The global aesthetic medicine market size is expected to reach USD 145.7 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.6% from 2022 to 2030. According to the International Association for Physicians in Aesthetic Medicine (IAPAM), aesthetic medicine is a branch of medicine focused on satisfying the aesthetic desires and goals of patients. The major aim of aesthetic medicine is to improve the physical appearance of the patient. Some key drivers of the market include the introduction of innovative aesthetic devices such as non-invasive aesthetic devices, a growing focus on physical appearance, and a rise in adoption among geriatric individuals.

Aesthetic medicine mainly includes invasive and non-invasive procedures. Invasive procedures include breast augmentation, liposuction, and nose reshaping while non-invasive procedures include popular technology such as Botox injections, soft tissue fillers, and chemical peel. The rise in the number of obesity cases in the U.S. has urged patients to opt for aesthetic treatments in the country. In the Asia Pacific region, the rise in the income level of the adult population in countries, such as China and India, is expected to create lucrative growth opportunities for the market. The region is also backed by South Korea, which is the hub of cosmetic surgeries.

The growing urge to look young and fit has increased the demand for aesthetic treatment in developing countries. Aesthetic procedures such as liposuction, nose reshaping, and Botox injections are gaining consumer interest in countries such as India and South Korea. Adults are paying attention to their physical appearance closely. This has increased the demand for cosmetic surgeries, with Botox being one of the most popular procedures preferred.

Aesthetic Medicine Market Report Highlights

  • Based on procedure type, the non-invasive procedures segment dominated the market in 2021 and is projected to maintain its lead throughout the forecast period owing to its quick and accurate results, along with the ease of usage compared to invasive procedures
  • In the invasive procedures segment, breast augmentation and liposuction are expected to witness significant growth over the forecast period
  • The Asia Pacific region is projected to register the fastest CAGR of 10.9% during the forecast period. Countries such as South Korea and India are expected to serve as key revenue pockets
Profiled Companies

AbbVie
Cynosure
Evolus Inc.
Revance Galderma
Lumenis
Solta Medical
Syneron Candela
Alma Laser

Please note The report will be delivered in 2-3 business days upon order notification.


Chapter
1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third-party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter
2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter
3. Aesthetic Medicine Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increasing adoption of minimally invasive treatments
3.3.1.2. Growing population aged between 25 and 65 years
3.3.2. Market Restraint Analysis
3.3.2.1. Lack of reimbursement coverage
3.3.2.2. Stringent regulatory framework
3.4. Aesthetic Medicine: Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier Power
3.4.1.2. Buyer Power
3.4.1.3. Substitution Threat
3.4.1.4. Threat from new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Environmental Landscape
3.4.2.3. Social Landscape
3.4.2.4. Technology Landscape
3.4.2.5. Legal Landscape
3.4.3. Major Deals & Strategic Alliances Analysis
Chapter
4. Aesthetic Medicine Market: Segment Analysis, By Procedure Type, 2017 - 2030 (USD Million)
4.1. Definitions & Scope
4.2. Procedure type market share analysis, 2021 & 2030
4.3. Global Aesthetic Medicine Market, By Procedure Type, 2017 to 2030
4.4. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
4.4.1. Invasive procedures
4.4.1.1. Breast augmentation
4.4.1.2. Liposuction
4.4.1.3. Nose reshaping
4.4.1.4. Eyelid Surgery
4.4.1.5. Tummy tuck
4.4.1.6. Others
4.4.2. Non-invasive procedure
4.4.2.1. Botox injections
4.4.2.2. Soft tissue fillers
4.4.2.3. Chemical peel
4.4.2.4. Laser hair removal
4.4.2.5. Microdermabrasion
4.4.2.6. Others
Chapter
5. Aesthetic Medicine Market: Regional Market Analysis, By Region, 2017 - 2030 (USD Million)
5.1. Definitions & Scope
5.2. Regional market share analysis, 2021 & 2030
5.3. Regional Market Dashboard
5.4. Regional Market: Key Players
5.5. Market Size, & Forecasts, and Trend Analysis, 2021 to 2030:
5.6. North America
5.6.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
5.6.2. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.6.3. U.S.
5.6.3.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.6.4. Canada
5.6.4.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.7. Europe
5.7.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
5.7.2. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.7.3. Germany
5.7.3.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.7.4. U.K.
5.7.4.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.7.5. France
5.7.5.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.7.6. Italy
5.7.6.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.7.7. Spain
5.7.7.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.8. Asia Pacific
5.8.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
5.8.2. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.8.3. China
5.8.3.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.8.4. Japan
5.8.4.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.8.5. India
5.8.5.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.8.6. Australia
5.8.6.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.8.7. South Korea
5.8.7.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.9. Latin America
5.9.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
5.9.2. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.9.3. Brazil
5.9.3.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.9.4. Mexico
5.9.4.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.9.5. Argentina
5.9.5.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.10. Middle East and Africa
5.10.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
5.10.2. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.10.3. South Africa
5.10.3.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.10.4. Saudi Arabia
5.10.4.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
5.10.5. UAE
5.10.5.1. Market estimates and forecast, by procedure type, 2017 - 2030 (USD Million)
Chapter
6. Aesthetic Medicine Market - Competitive Analysis
6.1. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
6.2. Vendor Landscape
6.2.1. List of key distributors and channel partners
6.3. Key companies profiled
6.3.1. AbbVie
6.3.1.1. Company Overview
6.3.1.2. Financial Performance
6.3.1.3. Product Benchmarking
6.3.1.4. Strategic Initiatives
6.3.2. Cynosure
6.3.2.1. Company Overview
6.3.2.2. Financial Performance
6.3.2.3. Product Benchmarking
6.3.2.4. Strategic Initiatives
6.3.3. Evolus Inc.
6.3.3.1. Company Overview
6.3.3.2. Financial Performance
6.3.3.3. Product Benchmarking
6.3.3.4. Strategic Initiatives
6.3.4. Revance Galderma
6.3.4.1. Company Overview
6.3.4.2. Financial Performance
6.3.4.3. Product Benchmarking
6.3.4.4. Strategic Initiatives
6.3.5. Lumenis
6.3.5.1. Company Overview
6.3.5.2. Financial Performance
6.3.5.3. Product Benchmarking
6.3.5.4. Strategic Initiatives
6.3.6. Solta Medical
6.3.6.1. Company Overview
6.3.6.2. Financial Performance
6.3.6.3. Product Benchmarking
6.3.6.4. Strategic Initiatives
6.3.7. Syneron Candela
6.3.7.1. Company Overview
6.3.7.2. Financial Performance
6.3.7.3. Product Benchmarking
6.3.7.4. Strategic Initiatives
6.3.8. Alma Laser
6.3.8.1. Company Overview
6.3.8.2. Financial Performance
6.3.8.3. Product Benchmarking
6.3.8.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings